Inomata
Challenging
Lab

2026/10/15[Conferences & Awards] Lab Director Takenori Inomata Selected for the 12th Cohort of the Mansfield–PhRMA Research Scholars Program and Completes U.S. Study Tour

Dr. Takenori Inomata, Director of Inomata Lab, was selected for the 12th cohort of the Mansfield–PhRMA Research Scholars Program, organized by the Maureen and Mike Mansfield Foundation. In September 2026, he participated in a two-week study tour of Washington, D.C., Philadelphia, and Boston.

Supported by the Pharmaceutical Research and Manufacturers of America (PhRMA), the program provides young and mid-career researchers from Japan with opportunities to learn about translational research, healthcare policy, and regulatory practices. Dr. Inomata was one of eight researchers selected for the 2026 cohort.www.phrma-jp.org

During the tour, he visited universities, research institutions, pharmaceutical companies, startup support facilities, and venture capital firms, exchanging views with local experts on how research discoveries can be translated into patient care. The experience highlighted the importance of integrating clinical needs, intellectual property, regulatory strategy, clinical development, funding, and commercialization from the earliest stages of research.

He also explored initiatives supporting medical innovation, including the use of AI, data infrastructure, and laboratory automation in research and development; partnerships between startups and pharmaceutical companies; and clinical trial data sharing. These visits offered valuable insights into the U.S. research and development ecosystem, where people with diverse expertise collaborate to turn scientific discoveries into meaningful benefits for patients.

During his visit, Dr. Inomata also returned to Schepens Eye Research Institute of Massachusetts Eye and Ear, where he worked from 2012 to 2015. Reuniting with former colleagues provided an opportunity to reflect on his development as a researcher and the value of international scientific exchange.

At Inomata Lab, we will draw on the knowledge and networks gained through this program to advance research and train the next generation of researchers in dry eye and corneal diseases, ocular surface immunology, regenerative medicine, AI, and digital health. Guided by clinical needs, we aim to translate our research into new diagnostic methods, treatments, and medical technologies that benefit patients.